Our Science

How Alnylam’s Manufacturing Investments Bring RNAi Therapeutics to More Patients, Faster

Anonymous — Tue, 30 Sep 2025 16:12:52 +0000

How Alnylam’s Manufacturing Investments Bring RNAi Therapeutics to More Patients, Faster Anonymous (not verified) Tue, 09/30/2025 - 16:12

Anonymous — Tue, 26 Aug 2025 20:20:44 +0000

RNAi Therapeutics: 5 Things You Should Know about this Innovative Class of Medicines Anonymous (not verified) Tue, 08/26/2025 - 20:20

Anonymous — Fri, 21 Feb 2025 19:15:03 +0000

A New Therapeutic Approach Seeks to Silence Devastating Neurological Diseases Anonymous (not verified) Fri, 02/21/2025 - 19:15

Anonymous — Thu, 26 Sep 2024 01:06:33 +0000

Confronting the World’s Leading Killer with a New Therapeutic Approach Anonymous (not verified) Thu, 09/26/2024 - 01:06

Anonymous — Thu, 12 Sep 2024 16:24:22 +0000

RNAi Therapeutics, from Possibility to Patients Anonymous (not verified) Thu, 09/12/2024 - 16:24

Anonymous — Tue, 01 Oct 2019 17:32:00 +0000

Building for Our Future Anonymous (not verified) Tue, 10/01/2019 - 17:32

Anonymous — Mon, 30 Apr 2018 20:43:55 +0000

Hunting for Targets: Bringing RNAi to Humans Anonymous (not verified) Mon, 04/30/2018 - 20:43

Anonymous — Mon, 30 Apr 2018 20:33:16 +0000

Building to Scale: Raising RNAi Therapeutics From Infancy Anonymous (not verified) Mon, 04/30/2018 - 20:33

Anonymous — Wed, 28 Feb 2018 21:19:56 +0000

Harnessing the Power of RNAi™: Pushing Through the Challenges and Setbacks Anonymous (not verified) Wed, 02/28/2018 - 21:19

Anonymous — Wed, 28 Feb 2018 20:50:04 +0000

RNAi Therapeutics: From Eureka! Moment to a Potential New Class of Medicines Anonymous (not verified) Wed, 02/28/2018 - 20:50